STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy ; volume:22 ; number:1 ; day:3 ; month:6 ; year:2024 ; pages:1-12 ; date:12.2024
Cell communication and signaling ; 22, Heft 1 (3.6.2024), 1-12, 12.2024

Creator: Rezabakhsh, Aysa
Sadaie, M. Reza
Ala, Alireza
Roosta, Yousef
Habtemariam, Solomon
Sahebnasagh, Adeleh
Khezri, Mohammad Rafi

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12964-024-01680-0

URN: urn:nbn:de:101:1-2408102121490.760491404728

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rezabakhsh, Aysa
Sadaie, M. Reza
Ala, Alireza
Roosta, Yousef
Habtemariam, Solomon
Sahebnasagh, Adeleh
Khezri, Mohammad Rafi
SpringerLink (Online service)

Other Objects (12)

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy

Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists

A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists

Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells

2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature

A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy

Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists

A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists

Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells

2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature

A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy

Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists

A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists

Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells

2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature

A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy

Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists

A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists

Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells

2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature

A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy

Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists

A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists

Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells

2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature

A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy

Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists

A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists

Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells

2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature

A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy

Related objects

Reset password